From April 21 to 23, CPHI Japan 2026 was grandly held in Tokyo, Japan. As a flagship event in the pharmaceutical industry across Asia and globally, this exhibition brought together over 800 premium exhibitors from more than 70 countries and regions worldwide, attracting over 35,000 professional visitors—including pharmaceutical experts, R&D leaders, procurement managers, and industry scholars—to explore emerging trends and opportunities in the global pharmaceutical sector.

During the exhibition, Changsha Luocheng Trading Co., Ltd. earned high recognition and collaborative opportunities from global industry partners through its professional technical expertise, comprehensive service system, and international brand image, bringing its Japan visit to a successful conclusion.

Mastery for Quality; Service Empowering the World

At this exhibition, Luocheng Trading showcased its full range of core peptide products, covering multiple fields such as metabolic diseases, digestion, and endocrinology. Several key products have completed DMF registration/filing in multiple countries including China, the United States, the European Union, South Korea, and Russia. With their advantages of high purity, high stability, and high biological activity, these products precisely meet the core demands of the high-end pharmaceutical market and have become the focal point of attention at the event.

In addition, Luocheng Trading offers one‑stop CRDMO services. From early‑stage R&D support to commercial‑scale production, it precisely meets clients’ customized needs through mature technical platforms, stable manufacturing capacity and a professional service team. This helps clients cut R&D costs, accelerate product launch timelines and enhance core competitiveness.

In terms of compliance management, Luocheng Trading consistently adheres to international standards with strict control over product quality and regulatory compliance. It has established a full‑process compliance system covering raw material procurement, production, finished‑product testing, warehousing and logistics. Equipped with advanced testing instruments and a dedicated compliance team, it safeguards product quality and safety from the source.

Expanding Global Footprint & Cooperation Network

During exhibitions, Luocheng Trading held in‑depth discussions with well‑known domestic pharmaceutical enterprises, innovative biotech firms and pharmaceutical traders. Multiple cooperation consensuses were reached regarding peptide API supply, customized production and technical collaboration.

In response to the growing global market demand, Luocheng Trading provides comprehensive professional support to clients worldwide through stable production capacity assurance, reliable product quality, and efficient service responsiveness. Meanwhile, it actively expands regional collaborations to continuously enhance its brand influence and competitiveness in the global market.
In line with the global trend of pharmaceutical industry upgrading, Luocheng Trading adheres to an international, high-quality, and professional development strategy, striving to become the most trusted peptide partner for clients across Asia and worldwide. The company is committed to enabling more high-quality peptide drugs to benefit patients globally and promoting the high-quality development of the global peptide industry.

Changsha Luocheng Trading Co., Ltd. is a specialized supplier of high-purity peptides for the cosmetic, wellness, and fitness industries. Our core products include cosmetic peptides, anti-aging peptides, weight management peptides, and muscle-building peptides – serving skincare brands, supplement formulators, and health-focused companies worldwide.